* The patients treated with the drug, tilrekimig, saw asignificant reduction in symptoms after 16 weeks and the drugwas well tolerated with a favorable safety profile […]
TOPLINE: Major depressive disorder (MDD) was prevalent among 32% of all individuals with cannabis use disorder (CUD) in a new meta-analysis, and CUD was prevalent among […]
Hypertensive disorders of pregnancy, chronic hypertension, and obesity are driving up rates of severe maternal morbidity in the US, a retrospective cohort study has found. “These […]
Infertility affects an estimated 15% of the global population, and male factors contribute to 40%-50% of cases. Increasing evidence suggests that exposure to toxins and pollutants […]
Oral tolvaptan was superior to fluid restriction at raising plasma sodium concentration (pNa) in adults with hyponatremia, and those treated with tolvaptan who needed intravenous (IV) […]
Key Points 1 in 5 women say they have already made a health decision based on inaccurate information, with consequences reported in nearly 40% of cases. […]
TOPLINE: Adult patients with Cushing syndrome who completed a 22-week trial of relacorilant therapy and continued treatment for 12 additional weeks preserved hypertension control and sustained […]
TOPLINE: A few exhaled volatile organic compounds — specifically decane and nonadecane — showed potential to identify allergic patients among those with chronic rhinitis, with 76.5% […]
Docket Number: FDA-2011-D-0605 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research The Food and Drug Administration (FDA) is announcing the availability of a […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.